Overview
- Defense Secretary Pete Hegseth announced mandatory testosterone testing for service members age 30 and older with voluntary offers of testosterone replacement therapy for low results.
- The Pentagon has not published key implementation details such as diagnostic thresholds, confirmatory testing rules, monitoring plans, cost estimates, or timelines for the program.
- Medical commentators warn a single, untimed blood test cannot reliably diagnose true testosterone deficiency and clinical guidelines call for symptom evaluation and repeat morning tests before starting treatment.
- Clinicians note testosterone replacement carries risks including infertility, higher red blood cell counts that can raise clot risk, sleep apnea, and prostate effects, and only a small fraction of men have clear medical need for therapy.
- The announcement has drawn political and legal pushback, with commentators criticizing the cultural messaging and a federal judge ordering expedited filings to probe how the program aligns with the administration’s ban on gender‑affirming hormone care.